scholarly article | Q13442814 |
P50 | author | Hisham A. Alhadlaq | Q39065576 |
Maqusood Ahamed | Q39065595 | ||
Mohd Javed Akhtar | Q57329520 | ||
Salman A Alrokayan | Q60776932 | ||
P2093 | author name string | Sudhir Kumar | |
P2860 | cites work | Structural basis for molecular recognition of folic acid by folate receptors | Q24307935 |
Systematic variation in gene expression patterns in human cancer cell lines | Q28145747 | ||
Molecular classification of cutaneous malignant melanoma by gene expression profiling | Q29619204 | ||
P921 | main subject | nanotechnology | Q11468 |
overexpression | Q61643320 | ||
P304 | page(s) | 78-92 | |
P577 | publication date | 2014-05-15 | |
P1433 | published in | Clinica Chimica Acta | Q5133740 |
P1476 | title | Targeted anticancer therapy: overexpressed receptors and nanotechnology | |
P478 | volume | 436 |
Q92326331 | Actively Targeted and Redox Responsive Delivery of Anticancer Drug by Chitosan Nanoparticles |
Q52684454 | Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug Activation. |
Q38966649 | Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma |
Q47241458 | Dually responsive mesoporous silica nanoparticles regulated by upper critical solution temperature polymers for intracellular drug delivery |
Q57809328 | Emerging Applications of Porphyrins and Metalloporphyrins in Biomedicine and Diagnostic Magnetic Resonance Imaging |
Q64947947 | Encapsulation of Gold Nanorods with Porphyrins for the Potential Treatment of Cancer and Bacterial Diseases: A Critical Review. |
Q64251799 | Extracellular Vesicles as Biological Shuttles for Targeted Therapies |
Q90074800 | High Surface Reactivity and Biocompatibility of Y2O3 NPs in Human MCF-7 Epithelial and HT-1080 FibroBlast Cells |
Q47370653 | Molecular photosensitisers for two-photon photodynamic therapy. |
Q38250517 | Nanoparticulate carriers: an emerging tool for breast cancer therapy |
Q40736574 | Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles |
Q90632686 | Recent Advances in Polymeric Nanocomposites of Metal-Organic Frameworks (MOFs) |
Q38557008 | Selective cancer-killing ability of metal-based nanoparticles: implications for cancer therapy. |
Q52757903 | Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity. |
Q97094559 | Silica-based organic-inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery |
Q28388753 | Silver nanoparticles induce degradation of the endoplasmic reticulum stress sensor activating transcription factor-6 leading to activation of the NLRP-3 inflammasome |
Q89597205 | Synthesis of New Cisplatin Derivatives from Bile Acids |
Q100503963 | Targeted delivery of 5-fluorouracil-1-acetic acid (5-FA) to cancer cells overexpressing epithelial growth factor receptor (EGFR) using virus-like nanoparticles |
Q39019352 | Targeting Nanocarriers with Anisamide: Fact or Artifact? |
Q26795601 | The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics |
Q39177093 | Towards understanding the distribution and tumor targeting of sericin regulated spherical calcium phosphate nanoparticles |
Q38648996 | Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy |
Q57469301 | Utilisation of Targeted Nanoparticle Photosensitiser Drug Delivery Systems for the Enhancement of Photodynamic Therapy |
Q38828904 | Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers? |
Search more.